Zobrazeno 1 - 10
of 495
pro vyhledávání: '"B. Ruggeri"'
Autor:
C.E. Gomez Camacho, B. Ruggeri
Publikováno v:
Chemical Engineering Transactions, Vol 64 (2018)
Despite the worldwide growth of Anaerobic Digestion (AD) plants able to produce biogas, further investigations on the cooperation of syntrophic organisms within mixed cultures are necessary. Microbiomes in AD bioreactors depend on process conditions,
Externí odkaz:
https://doaj.org/article/5128a747a4924f508ca3d72fad7e92c3
Publikováno v:
Chemical Engineering Transactions, Vol 57 (2017)
This study concerns with a theoretical investigation on the disposal and valorisation of Municipal Solid Waste (MSW) through a challenging approach, based on the separation of MSW into two different fractions: Refuse Derived Fuel (RDF) and Organic Fr
Externí odkaz:
https://doaj.org/article/9985377396b1423d8665ec4c634e61be
Publikováno v:
Chemical Engineering Transactions, Vol 38 (2014)
Currently, the biogas production from organic waste (OW) refuses through AD has been and continues to be one of the most widely used processes for energy production. Usually, AD is carried out in thermophilic (TC) or mesophilic conditions (MC); some
Externí odkaz:
https://doaj.org/article/1cc4f098a6374763b89bd48472c1a360
Publikováno v:
Chemical Engineering Transactions, Vol 38 (2014)
Olive oil production gives two high polluting refuses: the semisolid Olive Pomace (OP) and the liquid Olive Mill Wastewater (OMWW). These refuses actually present either from technology or from social point of views high disposal problems. An approac
Externí odkaz:
https://doaj.org/article/3424d66fa009449f8eb58748fe9b9b1a
Publikováno v:
Chemical Engineering Transactions, Vol 32 (2013)
In this work, we study the hydrogen production through a dark fermentation process by hydrogen forming bacteria consortium. In this sense, fermentation experiments are performed in a discontinuous reactor using glucose as the carbon source. Product a
Externí odkaz:
https://doaj.org/article/5437975e1a9a4f9385f98923672f116b
Publikováno v:
Chemical Engineering Transactions, Vol 25 (2011)
Abstract preview not available - see full-text PDF article.
Externí odkaz:
https://doaj.org/article/f81f51ea16b54f1da63b56b7f17e8b86
Publikováno v:
Chemical Engineering Transactions, Vol 25 (2011)
Abstract preview not available - see full-text PDF article.
Externí odkaz:
https://doaj.org/article/aef11f265b7e479bb9b5fcd3ee99b4ab
Autor:
Jordan M. Mattheisen, Chris Limberakis, Roger B. Ruggeri, Matthew S. Dowling, Christopher W. am Ende, Emilie Ceraudo, Thomas Huber, Christopher L. McClendon, Thomas P. Sakmar
Publikováno v:
Journal of the American Chemical Society. 145:11173-11184
Autor:
Allyn T. Londregan, Karlygash Aitmakhanova, James Bennett, Laura J. Byrnes, Daniel P. Canterbury, Xiayun Cheng, Thomas Christott, Jennifer Clemens, Steven B. Coffey, João M. Dias, Matthew S. Dowling, Gillian Farnie, Oleg Fedorov, Kimberly F. Fennell, Vicki Gamble, Carina Gileadi, Charline Giroud, Michael R. Harris, Brett D. Hollingshead, Kilian Huber, Magdalena Korczynska, Kimberly Lapham, Paula M. Loria, Arjun Narayanan, Dafydd R. Owen, Brigitt Raux, Parag V. Sahasrabudhe, Roger B. Ruggeri, Laura Díaz Sáez, Ingrid A. Stock, Benjamin A. Thuma, Andy Tsai, Alison E. Varghese
Publikováno v:
Journal of medicinal chemistry.
A series of small-molecule YEATS4 binders have been discovered as part of an ongoing research effort to generate high-quality probe molecules for emerging and/or challenging epigenetic targets. Analogues such as
Autor:
David A. Griffith, David J. Edmonds, Jean-Philippe Fortin, Amit S. Kalgutkar, J. Brent Kuzmiski, Paula M. Loria, Aditi R. Saxena, Scott W. Bagley, Clare Buckeridge, John M. Curto, David R. Derksen, João M. Dias, Matthew C. Griffor, Seungil Han, V. Margaret Jackson, Margaret S. Landis, Daniel Lettiere, Chris Limberakis, Yuhang Liu, Alan M. Mathiowetz, Jayesh C. Patel, David W. Piotrowski, David A. Price, Roger B. Ruggeri, David A. Tess
Publikováno v:
Journal of medicinal chemistry. 65(12)
Peptide agonists of the glucagon-like peptide-1 receptor (GLP-1R) have revolutionized diabetes therapy, but their use has been limited because they require injection. Herein, we describe the discovery of the orally bioavailable, small-molecule, GLP-1